Home » Topics » Regulatory

Regulatory
RSS

FDA approves Kisqali Femara Co-Pack

May 10, 2017

FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture

May 3, 2017

FDA grants accelerated approval to Alunbrig for ALK-positive NSCLC

May 2, 2017

FDA approves Rydapt for patients with newly diagnosed AML with FLT3 mutation

May 2, 2017

FDA grants accelerated approval to Imfinzi for previously treated bladder cancer

May 2, 2017

FDA approves Stivarga for second-line treatment of hepatocellular carcinoma

April 28, 2017

FDA approves Brineura to treat CLN2 disease

April 28, 2017

FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin

April 18, 2017

FDA grants approval for Ingrezza capsules for adults with tardive dyskinesia

April 12, 2017

FDA approves Austedo to treat chorea associated with Huntington's disease

April 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...